SPLIT-COURSE ACCELERATED THERAPY IN HEAD AND NECK-CANCER - AN ANALYSIS OF TOXICITY

被引：28

作者：

DELANEY, GP ^{[1
]}

FISHER, RJ ^{[1
]}

SMEE, RI ^{[1
]}

HOOK, C ^{[1
]}

BARTON, MB ^{[1
]}

机构：

[1] PRINCE WALES HOSP, DEPT RADIAT ONCOL, RANDWICK, NSW 2031, AUSTRALIA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1995年 / 32卷 / 03期

关键词：

SQUAMOUS CELL CANCER; HEAD AND NECK CANCER; ACCELERATED RADIOTHERAPY;

D O I：

10.1016/0360-3016(95)00093-E

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: To retrospectively assess a protocol of split-course accelerated radiation therapy (SCAT) for selected head and neck cancers. Methods and Materials: SCAT consisted of 1.8 Gy per fraction administered twice daily with a minimum gap between fractions of 6 h. The treatment protocol prescribed an initial 16 fractions followed by a planned 5 to 12 day break, and then a further 20 to 22 fractions for a total dose ranging from 64.8 to 72 Gy delivered in 5 to 6 weeks. Results: Twenty-eight patients received SCAT for histologically confirmed head and neck cancer between January 1987 and August 1991. All patients were followed up until December 1, 1993. The mean potential follow-up time was 4.2 years (range: 2.9-6.2 years). All patients completed the treatment protocol. Thirteen tumors were laryngeal in origin, eight hypopharyngeal, four paranasal sinus, and three oropharyngeal. There were no Stage I, three Stage II, nine Stage III, and 12 Stage IV tumors. Four tumors were not staged (two paranasal sinus cancers and two surgical recurrences). Early and late toxicities were moderate to severe. Confluent mucositis was experienced by 27 of the 28 patients (96%). One patient required a prolonged midtreatment break of 24 days. Nine patients (32%) required narcotic analgesia for pain relief. Eleven patients (39%) required hospitalization for nasogastric feeding or pain control. The median length of hospital stay was 14 days (range 7-98 days). The actuarial rate of severe late toxicity at 3 years was 47% (standard error (SE) = 13%). A complete tumor response was achieved in 86% of patients, The actuarial local control rate at 3 years was 43% (SE = 11%) and the actuarial survival rate at 3 years was 25% (SE = 8%). Conclusion: Given the encouraging complete response rate and local control for such advanced tumors, SCAT for locoregionally advanced tumors merits further investigation. However, because of the significant late toxicity observed, the total dose, interfraction interval, and fractionation technique used should be reconsidered.

引用

页码：763 / 768

页数：6

共 20 条

[1] Cox, Large dose fractionation, Cancer, 55, pp. 2105-2111, (1985)
[2] El-Badawi, Goepfert, Fletcher, Squamous cell carcinoma of the pyriform sinus, Laryngoscope, 92, pp. 357-364, (1982)
[3] Horiot, Le Fur, N'Guyen, Chenal, Schraub, Alfonsi, Gardani, Van Den Bogaert, Danczak, Bolla, Van Glabbeke, De Paun, Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomised trial of the EORTC co-operative group of radiotherapy, Radiother. Oncol., 25, pp. 231-241, (1992)
[4] International Commission on Radiation Units and Measurements, Dose specification for reporting external beam therapy with photons and electrons, Report 29, (1978)
[5] Kaanders, Van Daal, Hoogenraad, Van der Kogel, Accelerated fractionation radiotherapy for laryngeal cancer, acute and late toxicity, Int. J. Radiat. Oncol. Biol. Phys., 24, pp. 497-503, (1992)
[6] Kaplan, Meier, Nonparametric estimation from incomplete observations, Journal of the American Statistical Association, 53, pp. 457-481, (1958)
[7] Keane, Fyles, O'Sullivan, Barton, Baki, Simm, The effect of treatment duration in local control of squamous carcinoma of the tonsil and carcinoma of the cervix, Semin. Radiat. Oncol., 2, pp. 26-28, (1992)
[8] Lamb, Spry, Gray, Johnson, Alexander, Dally, Accelerated fractionation radiotherapy for advanced head and neck cancer, Radiother. Oncol., 18, pp. 107-116, (1990)
[9] Maciejewski, Preuss-Bayer, Trott, The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx, Int. J. Radiat. Oncol. Biol. Phys., 9, pp. 321-328, (1983)
[10] Meoz-Mendez, Fletcher, Guillamondegui, Analysis of the results of irradiation in the treatment of squamous cell carcinomas of the pharyngeal walls, Int. J. Radiat. Oncol. Biol. Phys., 4, pp. 579-585, (1978)

← 1 2 →